Martin Shkreli reported too-good-to-be-true returns, investor tells trial

An investor in “Pharma Bro” Martin Shkreli’s hedge fund says he wowed her by reporting eye-popping returns that prosecutors say were a lie.

Sarah Hassan testified Thursday as the first witness at Shkreli’s security fraud trial.

She told jurors she invested $ 300,000 US with Shkreli in 2011 after being told he was “a rising star in the hedge fund world” who managed $ 40 million US. She said she was thrilled when he reported she made nearly $ 60,000 US that year alone.

But prosecutors say Shkreli was concealing the fact that his fund was tanking because of bad stock bets.

The 34-year-old Shkreli is notorious for raising the price of a life-saving drug 5,000 per cent and for his nonstop social media posturing.

His lawyers say he’s a nerdy eccentric who’s innocent.

Let’s block ads! (Why?)

CBC | Health News